(06 Aug 2020) Hydroxychloroquine- did not prevent illness compatible with Covid-19
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://www.nejm.org/doi/full/10.1056/NEJMoa2016638 In this randomized, double-blind, placebo-controlled trial (NCT04308668. opens in new tab), the efficacy of hydroxychloroquine as Covid-19 postexposure prophylaxis was investigated. In this trial, high doses of hydroxychloroquine did… Continue reading "(06 Aug 2020) Hydroxychloroquine- did not prevent illness compatible with Covid-19"